TuHURA Biosciences Capital Expenditures (CapEx) Growth & History (HURA)
TuHURA Biosciences's capital expenditures (capex) was $76,083 for fiscal 2025.
View full TuHURA Biosciences company overviewTuHURA Biosciences annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $76,083 | $18,177 | +31.39% |
| 2024 · Dec 31 | 2024-12-31 | $57,906 | −$21,318 | −26.91% |
| 2024 · Jun 30 | 2024-06-30 | $899,000 | −$192,000 | −17.60% |
| 2023 · Dec 31 | 2023-12-31 | $79,224 | $42,947 | +118.39% |
| 2023 · Jun 30 | 2023-06-30 | $1.1M | $911,000 | +506.11% |
| 2022 | 2022-12-31 | $36,277 | — | — |
| 2022 | 2022-06-30 | $180,000 | $92,000 | +104.55% |
| 2021 | 2021-06-30 | $88,000 | $8,000 | +10.00% |
| 2020 | 2020-06-30 | $80,000 | $90 | +0.11% |
| 2019 | 2019-06-30 | $79,910 | $0 | 0.00% |
| 2018 | 2018-06-30 | $79,910 | $12,649 | +18.81% |
| 2017 | 2017-06-30 | $67,261 | $20,956 | +45.26% |
| 2016 | 2016-06-30 | $46,305 | — | — |
TuHURA Biosciences quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $136,978 | $131,417 | +2363.19% |
| Q1 2026 | 2026-03-31 | $48,846 | $6,174 | +14.47% |
| Q4 2025 | 2025-12-31 | $27,850 | — | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $5,561 | −$14,439 | −72.19% |
| Q1 2025 · Mar 31 | 2025-03-31 | $42,672 | $42,672 | — |
| Q1 2025 · Sep 30 | 2024-09-30 | $0 | −$859,000 | — |
| Q4 2024 | 2024-06-30 | $20,000 | −$212,000 | −91.38% |
| Q1 2024 · Mar 31 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $20,000 | $20,000 | — |
| Q1 2024 · Sep 30 | 2023-09-30 | $859,000 | $0 | 0.00% |
| Q4 2023 | 2023-06-30 | $232,000 | — | — |
| Q3 2023 | 2023-03-31 | $0 | — | — |
| Q2 2023 | 2022-12-31 | $0 | — | — |
| Q1 2023 | 2022-09-30 | $859,000 | — | — |
| Q3 2016 | 2016-03-31 | $0 | — | — |
TuHURA Biosciences capital expenditures (capex) trends
Between the periods ended 2016-06-30 and 2025-12-31, TuHURA Biosciences's capital expenditures (capex) increased from $46,305 to $76,083, a change of $29,778. The latest reported quarter, Q2 2026, shows $136,978.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TuHURA Biosciences source filings ↗